Judith N. Steenbergen

5.6k citations
74 papers · 4.4k indexed · 1 hit paper · h-index 33
Topics
Antibiotic Resistance in Bacteria (32 papers)Antibiotics Pharmacokinetics and Efficacy (25 papers)Antimicrobial Resistance in Staphylococcus (22 papers)

In The Last Decade

Judith N. Steenbergen

73 papers receiving 4.3k citations

Hit Papers

Ceftolozane-tazobactam compared with levofloxacin in the ...2015202620182022201550100150200250

Peers

Judith N. Steenbergen
Comparison fields: 5 of 116
  • Epidemiology 1.9k
  • Infectious Diseases 1.8k
  • Molecular Medicine 1.5k
  • Pharmacology 1.3k
  • Molecular Biology 880
Replace Yingchun Xu with:
Yingchun Xu China
Ian A. Critchley United States
Jong Hee Shin South Korea
Nicholas A. Kartsonis United States
Luciano Zubaran Goldani Brazil
Wright W. Nichols United States
Jung‐Chung Lin Taiwan
Roberta Fontana Italy
Koichi Izumikawa Japan
Azita Leavitt Israel
Judith N. Steenbergen relative to Yingchun Xu China Yingchun Xu's profile →
Citations per field
00.5×1.5×2.3×
Yingchun Xu · 1×
Citations per year

Countries citing papers authored by Judith N. Steenbergen

Since Specialization
Citations

This map shows the geographic impact of Judith N. Steenbergen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith N. Steenbergen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith N. Steenbergen more than expected).

Fields of papers citing papers by Judith N. Steenbergen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith N. Steenbergen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith N. Steenbergen. The network helps show where Judith N. Steenbergen may publish in the future.

Co-authorship network of co-authors of Judith N. Steenbergen

This figure shows the co-authorship network connecting the top 25 collaborators of Judith N. Steenbergen. A scholar is included among the top collaborators of Judith N. Steenbergen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith N. Steenbergen. Judith N. Steenbergen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 12
3 11
4 73
5 11
6 95
7 83
8
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)breakdown →
286
9 93
10 6
11 74
12 28
13 422
14 41
15 134
16 128
17 162
18 376
19 85
20 5

About Judith N. Steenbergen

Judith N. Steenbergen is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 74 papers that have together received 4.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (32 papers), Antibiotics Pharmacokinetics and Efficacy (25 papers) and Antimicrobial Resistance in Staphylococcus (22 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (638 citations), Molecular Medicine (1.5k citations) and Infectious Diseases (1.8k citations). Judith N. Steenbergen has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Arturo Casadevall, Grace M. Thorne, Joshua D. Nosanchuk, Howard A. Shuman, Jeff Alder, Francis P. Tally, Guojun Yuan, Obiamiwe Umeh, Stephen Villano and Stephanie D. Malliaris. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026